首页> 外文期刊>European journal of human genetics: EJHG >Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
【24h】

Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.

机译:鉴定具有特发性矮小身材的家庭中包括上游SHOX增强子的第一个PAR1缺失。

获取原文
获取原文并翻译 | 示例
       

摘要

Short stature homeobox-containing gene, MIM 312865 (SHOX) is located within the pseudoautosomal region 1 (PAR1) of the sex chromosomes. Mutations in SHOX or its downstream transcriptional regulatory elements represent the underlying molecular defect in ~60% of Leri-Weill dyschondrosteosis (LWD) and ~5-15% of idiopathic short stature (ISS) patients. Recently, three novel enhancer elements have been identified upstream of SHOX but to date, no PAR1 deletions upstream of SHOX have been observed that only encompass these enhancers in LWD or ISS patients. We set out to search for genetic alterations of the upstream SHOX regulatory elements in 63 LWD and 100 ISS patients with no known alteration in SHOX or the downstream enhancer regions using a specifically designed MLPA assay, which covers the PAR1 upstream of SHOX. An upstream SHOX deletion was identified in an ISS proband and her affected father. The deletion was confirmed and delimited by array-CGH, to extend ~286 kb. The deletion included two of the upstream SHOX enhancers without affecting SHOX. The 13.3-year-old proband had proportionate short stature with normal GH and IGF-I levels. In conclusion, we have identified the first PAR1 deletion encompassing only the upstream SHOX transcription regulatory elements in a family with ISS. The loss of these elements may result in SHOX haploinsufficiency because of decreased SHOX transcription. Therefore, this upstream region should be included in the routine analysis of PAR1 in patients with LWD, LMD and ISS.
机译:包含矮小同源盒的基因MIM 312865(SHOX)位于性染色体的假常染色体区域1(PAR1)中。 SHOX或其下游转录调控元件的突变代表了约60%的Leri-Weill软骨发育不良(LWD)和约5-15%的特发性矮小身材(ISS)患者的潜在分子缺陷。最近,已经在SHOX的上游发现了三种新型的增强子,但是迄今为止,没有观察到SHOX上游的PAR1缺失仅包含LWD或ISS患者中的这些增强子。我们着手使用专门设计的MLPA分析法(包括SHOX上游的PAR1),搜寻63名LWD和100名ISS患者中SHOX或下游增强子区域没有已知改变的上游SHOX调控元件的遗传改变。在ISS先证者和她受影响的父亲中鉴定出上游SHOX缺失。确认缺失并通过阵列-CGH定界,以延伸〜286kb。该删除包括两个上游SHOX增强子,而不会影响SHOX。这位13.3岁的先证者的矮小身材与正常的GH和IGF-I水平相称。总之,我们已经确定了首个PAR1缺失,仅包含ISS家族中的上游SHOX转录调控元件。这些元素的丢失可能会由于SHOX转录降低而导致SHOX单倍功能不足。因此,LWD,LMD和ISS患者的PAR1常规分析中应包括该上游区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号